证券代码：688622 证券简称：禾信仪器 广州禾信仪器股份有限公司 投资者关系活动记录表 编号：2022-006 | --- | --- | --- | |-----------------------|------------------------------------------------|----------------------------------------------------------| | | | | | | ■特定对象调研 □分析师会议 | | | | □媒体采访 □业绩说明会 | | | 投资者关系活动 | □新闻发布会 □路演活动 | | | 类别 | ■现场参观 ■其他 腾讯视频会议、电话会议 | | | | | | | | | 华创证券、混沌投资、高信百诺、华商基金、信达证券、财通 | | 参与单位名称 | 万家基金、南方基金 | 证券、广发证券、宝盈基金、长城基金、西南证券、华宝基金、 | | 时间 地点 | 2022 年 5 月 9 日 -2022 公司会议室 | 年 5 月 31 日 | | 上市公司接待人 员姓名 | 董事、董事会秘书：陆万里 证券事务代表： ...

证券代码：688622 证券简称：禾信仪器 广州禾信仪器股份有限公司 投资者关系活动记录表 编号：2022-007 | --- | --- | --- | |------------------------------|---------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------| | | ■特定对象调研 □分析师会议 | | | | □媒体采访 □业绩说明会 | | | 投资者关系活动 类别 | □新闻发布会 □路演活动 ■现场参观 ■其他 腾讯视频会议、电话会议 | | | 参与单位名称 | 金、中银基金、中融基金、财通证券 | 广发基金、民生证券、工商银行、农业银行、嘉实基金、华商 ...

2022 年第三季度报告 证券代码：688622 证券简称：禾信仪器 广州禾信仪器股份有限公司 2022 年第三季度报告 □是 √否 一、 主要财务数据 主要会计数据和财务指标 单位：元 币种：人民币 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、 完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告 中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 | 项目 | 本报告期 | 上年同期 | | 本报告 期比上 年同期 | 年初至报告 | 上年同期 | | 年初至 报告期 末比上 年同期 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 增减变 | | | | | | | | | | 动幅度 | 期末 | | | 增减变 | | | | | | ...

Financial Performance - The company reported a revenue of RMB 100 million for the first half of 2022, representing a year-on-year increase of 15%[1] - The company's operating revenue for the first half of 2022 was ¥109,406,579.76, a decrease of 14.62% compared to ¥128,136,617.83 in the same period last year[19] - The net profit attributable to shareholders of the listed company was -¥16,988,503.12, representing a decline of 215.13% from ¥14,755,775.62 in the previous year[19] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥31,180,803.73, a significant drop of 2,071.74% compared to ¥1,581,384.45 in the same period last year[19] - The net cash flow from operating activities was -¥66,672,411.09, worsening from -¥50,066,530.43 in the previous year[19] - The total assets at the end of the reporting period were ¥846,671,715.74, a decrease of 9.10% from ¥931,395,210.90 at the end of the previous year[19] - The net assets attributable to shareholders of the listed company were ¥576,353,245.99, down 4.75% from ¥605,122,842.16 at the end of the previous year[19] - Basic earnings per share for the reporting period is -0.24 CNY, a decrease of 185.71% compared to the same period last year[20] - The weighted average return on equity decreased by 8.58 percentage points to -2.86%[20] Revenue Projections and Growth - The company expects a revenue growth of 10% to 15% for the second half of 2022, projecting total revenue between RMB 110 million and RMB 115 million[1] - New product launches are anticipated to contribute an additional RMB 20 million in revenue by the end of 2022[1] - The company is expanding its market presence in Southeast Asia, targeting a 25% market share in the region by 2025[1] Research and Development - Research and development expenses increased by 30% to RMB 15 million, focusing on innovative technologies and product enhancements[1] - R&D expenditure accounted for 28.53% of operating revenue, an increase of 12.75 percentage points year-on-year[21] - The total R&D expenditure for the period was ¥31,219,002.60, representing a 54.39% increase compared to ¥20,220,621.79 in the same period last year[45] - The company has a total of 411 intellectual property applications, with 234 granted, including 76 software copyrights[43] - The company applied for 9 new domestic invention patents during the reporting period, of which 3 were granted, bringing the total to 45 granted invention patents[43] - The company is currently developing high-stability high-frequency power supplies and automated sample processing systems, with a total investment of ¥10,000,000 for the project[48] - A project aimed at developing high-resolution mass spectrometry has received ¥22,800,000 in total investment, with ongoing testing and verification[48] - The company has completed a project for a portable gas chromatography-mass spectrometry system, with an investment of ¥7,500,000, which is now ready for market[48] Market and Competitive Landscape - The global mass spectrometer market is highly concentrated, primarily dominated by international giants such as Waters, Danaher, and Agilent, with North America holding the largest market share[35] - In the first half of 2022, China imported 7,173 mass spectrometers, indicating a high reliance on foreign high-end products[36] - The Chinese government has introduced multiple policies to support the development of domestic high-end analytical instruments, signaling positive growth for the mass spectrometer industry[38] - The company focuses on high-end mass spectrometer R&D, production, and sales, achieving strong brand advantages in PM2.5, VOCs, and O3 monitoring within the atmospheric environment monitoring sector[39] Risks and Challenges - The company has identified potential risks related to supply chain disruptions and is implementing measures to mitigate these risks[1] - The company faced risks related to core competitiveness, including potential R&D failures and technology updates, which could adversely affect its sustainable development[65][68] - The company is exposed to risks from concentrated downstream application fields, particularly in atmospheric environmental monitoring, which is its main revenue source[70] - The company is at risk of inventory depreciation due to slow turnover and potential market demand changes, which could lead to unsold products[73] Employee and Compensation - The number of R&D personnel increased to 161, accounting for 21.16% of the total workforce, up from 20.06% in the same period last year[52] - The average salary of R&D personnel rose to 11.84 million RMB, compared to 8.92 million RMB in the previous year, indicating a focus on attracting and retaining talent[52] - The company reported an increase in employee compensation expenses due to an increase in personnel scale[85] Environmental and Social Responsibility - The company is actively engaged in carbon emission reduction strategies, including consulting services and monitoring systems, to support national carbon neutrality goals[101] - The company has implemented energy-saving measures, such as paperless office processes, to reduce resource consumption and greenhouse gas emissions[102] - The company has established a comprehensive carbon monitoring and assessment system to support its environmental initiatives[101] Shareholder Commitments and Governance - The company has committed to strict adherence to share lock-up agreements, with any unfulfilled commitments resulting in the forfeiture of corresponding gains[110] - The commitments made by shareholders are aimed at maintaining market stability and protecting the interests of all investors[137][140] - The company emphasizes compliance with the laws and regulations regarding share reduction and information disclosure[139][141] - The company will implement measures to minimize investor losses if commitments are not met due to force majeure[199]

2022 年第一季度报告 证券代码：688622 证券简称：禾信仪器 广州禾信仪器股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上年同 期增减变动幅度(%) | | --- | --- | --- | | 营业收入 | 45,134,456.52 | -9.26 | | 归属于上市公司股东的净利润 | -12,333,292.83 | -1,358.63 | | 归属于上市公司股东的扣除非经常 性损益的净利润 | -18,930,289.09 | 不适用 | | 经营活动产生的现金流量净额 | -80,054,513.03 | 不适用 | | 基本每股收益（元/股） | -0.18 | -980.98 | 1 / 14 2022 年第一季度报告 | 稀释每股收益（元/股） | -0.18 | | | -980.98 | | | --- | --- | --- | --- | --- | --- | | 加权 ...

Financial Performance - The proposed cash dividend for 2021 is CNY 1.7 per 10 shares, totaling CNY 11,899,593.02 (including tax), which represents 15.14% of the net profit attributable to shareholders of the parent company[5]. - The company's operating revenue for 2021 was CNY 464,237,256.58, representing a 48.66% increase compared to CNY 312,272,106.42 in 2020[23]. - The net profit attributable to shareholders for 2021 was CNY 78,574,746.75, a 13.13% increase from CNY 69,453,951.06 in 2020[23]. - The net profit after deducting non-recurring gains and losses was CNY 44,330,006.80, showing a decrease of 14.29% from CNY 51,719,010.62 in 2020[23]. - The net cash flow from operating activities decreased by 76.71% to CNY 14,928,899.58 from CNY 64,087,116.55 in 2020[23]. - The total assets at the end of 2021 were CNY 931,395,210.90, a 69.35% increase from CNY 549,979,328.90 at the end of 2020[23]. - The net assets attributable to shareholders increased by 141.45% to CNY 605,122,842.16 from CNY 250,624,681.24 in 2020[23]. - The basic earnings per share for 2021 were CNY 1.38, a 4.55% increase from CNY 1.32 in 2020[24]. - The diluted earnings per share for 2021 were also CNY 1.38, consistent with the basic earnings per share[24]. Research and Development - Research and development (R&D) investment reached RMB 53,219,249.98, a year-on-year increase of 36.56%[35]. - The R&D expenditure as a percentage of operating revenue was 11.46%, down by 1.02 percentage points from 12.48% in 2020[24]. - The company expanded its R&D team to 167 personnel, representing 21.19% of the total workforce[35]. - The company has applied for 50 new patents, including 35 invention patents and 15 utility model patents, enhancing its intellectual property portfolio[35]. - The company has achieved significant advancements in core technologies, maintaining a leading position in domestic development across various applications, including environmental monitoring and food safety[64]. - The company has not capitalized any R&D expenditures, maintaining a focus on immediate operational needs[70]. - The company is committed to independent innovation and the localization of high-end mass spectrometers, competing against international giants in the industry[58]. Market and Competitive Landscape - The company focuses on high-end mass spectrometers, with significant market potential in healthcare, food safety, and environmental monitoring, driven by increasing government investment and public concern[55]. - The domestic mass spectrometer market is primarily dominated by foreign products, with high-end mass spectrometers mainly relying on imports, which limits the effective exploration of potential user demand in various industries[135]. - The company aims to enhance its core competitiveness and market share in domestic mass spectrometers by expanding into air quality monitoring, water quality monitoring, medical health, and food safety applications[138]. - The company is exposed to competition in the environmental monitoring field, which may pressure product pricing and profit margins[93]. Governance and Compliance - The company has established a robust corporate governance structure, holding multiple board meetings and ensuring effective decision-making processes[144]. - The company did not have any dissenting opinions from board members regarding company matters during the reporting period[172]. - The company is committed to maintaining compliance with regulatory requirements as outlined by the Company Law and the China Securities Regulatory Commission[173]. - The audit committee's responsibilities included reviewing financial reports and internal audit plans, ensuring transparency and accountability[174]. Strategic Initiatives - The company plans to enhance R&D efforts and expand product applications to compete with international giants in the mass spectrometry market[134]. - The company plans to continue the development and industrialization of new products, including automatic microbial detection mass spectrometers and triple quadrupole mass spectrometers, to meet increasing market demands[139]. - The company is committed to improving its service and technical support systems, which are becoming critical factors for customers when selecting mass spectrometers[136]. - The company plans to enhance its digital marketing strategy, allocating an additional 5% of revenue towards online advertising in 2022[155]. Employee and Labor Management - The total number of employees in the parent company and major subsidiaries is 788, with 335 in technical roles and 167 in research and development[180]. - The company emphasizes employee training and development, aiming to enhance skills and career growth through various training programs[182]. - Total remuneration for all directors, supervisors, and senior management was CNY 4.6004 million[166]. Environmental and Social Responsibility - The company emphasizes ESG practices, focusing on environmental protection, social responsibility, and corporate governance to achieve high-quality development[194]. - The company has not faced any administrative penalties related to environmental issues during the reporting period, complying with national and local environmental protection requirements[198]. - The company actively manages resource consumption, implementing measures to reduce energy and water usage in production and operations[200].

Financial Performance - The company's operating revenue for Q3 2021 was ¥112,560,149.98, representing a year-on-year increase of 36.29%[5] - The net profit attributable to shareholders for Q3 2021 was ¥24,532,522.71, reflecting a year-on-year increase of 14.49%[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥15,607,968.41, showing a decrease of 10.60% compared to the same period last year[5] - The basic and diluted earnings per share for Q3 2021 were both ¥0.47, an increase of 14.49% year-on-year[6] - The total operating revenue for the first three quarters of 2021 reached ¥240,696,767.81, a significant increase of 50.94% compared to ¥159,362,721.95 in the same period of 2020[19] - The net profit attributable to the parent company's shareholders was ¥39,288,298.33, an increase of 30.5% from ¥30,087,156.97 in the same period last year[21] - The basic earnings per share for the current period was ¥0.75, compared to ¥0.57 in the previous year, representing a growth of 31.6%[22] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,004,846,659.20, marking an increase of 82.71% compared to the end of the previous year[6] - The total liabilities increased to ¥448,761,682.79 from ¥303,454,522.08, which is a rise of 48%[17] - Non-current assets totaled ¥231,577,247.59, up from ¥154,071,860.23, marking an increase of 50.3%[17] - Total assets reached ¥1,004,846,659.20, compared to ¥549,979,328.90, reflecting a growth of 82.5%[17] - Total current assets reached RMB 773,269,411.61, up from RMB 395,907,468.67 year-over-year[15] - The company reported a deferred income of 31,879,604.08, indicating future revenue recognition[29] - The long-term payables were recorded at 2,750,000.00, reflecting the company's long-term financial commitments[29] Shareholder Information - The equity attributable to shareholders at the end of the reporting period was ¥563,511,683.58, an increase of 124.84% year-on-year[6] - The total number of ordinary shares at the end of the reporting period was 3,921[12] - The largest shareholder, Zhou Zhen, holds 14,609,675 shares, representing 20.87% of total shares[12] - The total number of shareholders was not specified, but the top ten shareholders hold a significant portion of the company[12] Research and Development - Research and development expenses totaled ¥12,427,982.22, which accounted for 11.04% of operating revenue, an increase of 0.19 percentage points from the previous year[6] - The company reported a significant increase in research and development expenses, which rose to ¥30,663,377.86 from ¥22,390,343.44, a growth of 37%[20] - The company has increased its investment in R&D projects, with material costs for R&D rising approximately 65% year-on-year and employee compensation for R&D staff increasing by 30.3%[10] Cash Flow and Investments - Operating cash inflow for the first three quarters of 2021 reached CNY 333.75 million, a 70.4% increase from CNY 195.89 million in the same period of 2020[24] - Net cash outflow from operating activities was CNY -61.17 million, compared to CNY -39.28 million in the previous year, indicating a worsening cash flow situation[25] - Cash and cash equivalents at the end of Q3 2021 totaled CNY 336.79 million, significantly up from CNY 82.74 million at the end of Q3 2020[26] - The company raised CNY 285.68 million from investment activities in 2021, compared to no funds raised in the same period of 2020[25] - Cash outflow from investment activities was CNY 152.35 million, down from CNY 183.62 million in the previous year, indicating reduced investment spending[25] - Financing activities generated a net cash inflow of CNY 332.76 million, a significant increase from CNY 43.57 million in the same period of 2020[25] Operational Insights - The company reported a significant increase in hardware sales, which grew by 61% year-on-year, contributing to overall revenue growth[10] - The company has not disclosed any new product developments or market expansion strategies in the current report[14] - There are no significant reminders or additional important information regarding the company's operational situation during the reporting period[14] - The company has plans for market expansion and new product development, although specific details were not disclosed in the report[18]

Financial Performance - The company's operating revenue for Q3 2021 was ¥112,560,149.98, representing a year-on-year increase of 36.29%[5] - The net profit attributable to shareholders was ¥24,532,522.71, reflecting a growth of 14.49% compared to the same period last year[5] - The basic earnings per share for the quarter was ¥0.47, an increase of 14.49% year-on-year[6] - Total revenue for the first three quarters of 2021 reached ¥240,696,767.81, a significant increase of 50.94% compared to ¥159,362,721.95 in the same period of 2020[22] - Net profit for the third quarter of 2021 was ¥33,443,081.89, representing a 17.73% increase from ¥28,437,556.90 in the same quarter of 2020[23] - The company reported a total of ¥39,288,298.33 in net profit attributable to shareholders for the third quarter of 2021, compared to ¥30,087,156.97 in the same quarter of 2020, indicating a growth of 30.54%[24] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,004,846,659.20, up 82.71% from the end of the previous year[6] - As of September 30, 2021, the company's total current assets reached ¥773,269,411.61, a significant increase from ¥395,907,468.67 on December 31, 2020, representing an increase of approximately 95.4%[17] - Total assets as of the end of the third quarter of 2021 amounted to ¥1,004,846,659.20, up from ¥549,979,328.90 at the end of the third quarter of 2020, marking an increase of 82.43%[19] - Total liabilities reached ¥448,761,682.79, an increase of 47.83% from ¥303,454,522.08 in the previous year[19] - The company's total assets as of September 30, 2021, were CNY 549,979,328.90, a decrease from CNY 552,922,703.45 at the beginning of the year[29] - Total liabilities amounted to CNY 303,454,522.08, down from CNY 306,397,896.63 at the beginning of the year[30] Cash Flow - The company reported a cash flow from operating activities of -¥61,168,444.46 for the year-to-date[5] - In the first three quarters of 2021, the company generated cash inflows from operating activities amounting to CNY 333,754,603.19, a 70.4% increase compared to CNY 195,893,878.96 in the same period of 2020[25] - The net cash flow from operating activities for the first three quarters of 2021 was -CNY 61,168,444.46, worsening from -CNY 39,283,719.49 in the previous year[25] - Cash inflows from investment activities totaled CNY 51,152,632.59, down 61.4% from CNY 132,480,393.72 in the same period of 2020[26] - The net cash flow from investment activities was -CNY 101,195,837.27, compared to -CNY 51,137,420.36 in the previous year, indicating increased cash outflows[26] - The net cash flow from financing activities was CNY 332,762,702.78, compared to CNY 43,574,663.39 in the previous year, showing a substantial improvement[26] Research and Development - Research and development expenses totaled ¥12,427,982.22, which is 11.04% of operating revenue, marking an increase of 0.19 percentage points[6] - The company experienced a 61% increase in hardware sales year-on-year, contributing to overall revenue growth[10] - R&D material costs increased by approximately 65%, and the number of R&D personnel grew, leading to a 30.3% rise in employee compensation[10] - Research and development expenses for the third quarter of 2021 were ¥30,663,377.86, an increase of 37.06% compared to ¥22,390,343.44 in the same quarter of 2020[23] Equity and Reserves - Shareholders' equity totaled ¥556,084,976.41, up 125.66% from ¥246,524,806.82 in the same period of 2020[19] - Total equity attributable to shareholders reached ¥250,624,681.24, reflecting a strong financial position[31] - Unallocated profits amounted to ¥164,978,459.91, indicating retained earnings for future growth[31] - Capital reserve was recorded at ¥15,675,512.61, contributing to the company's equity base[31] - Surplus reserve totaled ¥17,473,102.72, indicating a buffer for future contingencies[31] - The financial report reflects a stable equity structure, essential for investor confidence[31] Future Outlook - The company has not disclosed any new product launches or technological advancements in the current report[15] - Future outlook and performance guidance were not explicitly mentioned in the provided documents, indicating a need for further clarification in subsequent communications[15]